订阅小程序
旧版功能

Application of Plasma Circulating KRAS Mutations As a Predictive Biomarker for Targeted Treatment of Pancreatic Cancer.

M. R. Lee,S. M. Woo,M. K. Kim,S. S. Han,S. J. Park, W. J. Lee,D. E. Lee,S. Choi,W. Choi,K. A. Yoon,J. W. Chun,Y. H. Kim,S. Y. Kong

Cancer Science（2024）

引用 2|浏览36
关键词
circulating tumor DNA,KRAS,KRAS G12C inhibitor,pancreatic ductal adenocarcinoma,patient-derived organoid
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要